---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-021654"
form_type: "8-K"
ticker: "IBIO"
cik: "0001420720"
company_name: "iBio, Inc."
filed_at: "2026-02-27T23:59:59+00:00"
generated_at: "2026-05-15T23:01:06.554500+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# iBio enters $100M at-the-market equity agreement with Jefferies, terminates prior ATM

## Summary
- Entered Open Market Sale Agreement (ATM) with Jefferies LLC for up to $100M of common stock.
- Jefferies will receive up to 3.0% commission on gross proceeds from sales.
- Terminated prior ATM agreement with Chardan Capital Markets and Craig-Hallum that allowed up to $7.35M.
- Sales under new ATM to be made via Nasdaq or in privately negotiated transactions, subject to conditions.
- Shelf registration statement filed Feb 27, 2026; no assurance of effectiveness.

## SEC filing metadata
- accession: 0001104659-26-021654
- form_type: 8-K
- ticker: IBIO
- cik: 0001420720
- company_name: iBio, Inc.
- filed_at: 2026-02-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420720/000110465926021654/0001104659-26-021654-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420720/000110465926021654/tm267467d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-021654
- JSON: https://secwatch.observer/filing/0001104659-26-021654.json
- Plain text: https://secwatch.observer/filing/0001104659-26-021654.txt

## Key facts
- Material Agreements
  iBio, Inc. terminated At Market Issuance Sales Agreement with Chardan Capital Markets, LLC and Craig-Hallum Capital Group LLC valued at aggregate offering price of up to $7,350,000 (effective 2026-02-23).
  - Action: termination
  - Agreement: atm program
  - Counterparty: Chardan Capital Markets, LLC and Craig-Hallum Capital Group LLC
  - Value: aggregate offering price of up to $7,350,000
  - Effective: 2026-02-23
  source text: On February 23, 2026, the Company provided notice terminating the At Market Issuance Sales Agreement (the “Prior ATM Agreement”), dated July 3, 2024, between the Company and Chardan Capital Markets, LLC and Craig-Hallum Capital Group LLC.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1420720/000110465926021654/0001104659-26-021654-index.htm
- Material Agreements
  iBio, Inc. entered into Open Market Sale Agreement SM with Jefferies LLC valued at up to $100,000,000 (effective 2026-02-27).
  - Action: entry
  - Agreement: atm program
  - Counterparty: Jefferies LLC
  - Value: up to $100,000,000
  - Effective: 2026-02-27
  source text: On February 27, 2026, iBio, Inc., a Delaware corporation (the “Company”), entered into an Open Market Sale Agreement SM (the “ATM Agreement”) with Jefferies LLC (“Jefferies”) providing for the sale by the Company of its shares of common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1420720/000110465926021654/0001104659-26-021654-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.